STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$6.73
-0.11 (-1.61%)
Open$7.02
Previous Close$6.84
Day High$7.09
Day Low$6.54
52W High$8.33
52W Low$1.70
Volume—
Avg Volume2.09M
Market Cap673.94M
P/E Ratio—
EPS$-0.51
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+630.2% upside
Current
$6.73
$6.73
Target
$49.14
$49.14
$35.75
$49.14 avg
$66.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.60M | 1.38M | 31.76M |
| Net Income | -77,874,962 | -60,713,327 | 1.18M |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% |
| EBITDA | -76,298,366 | -62,788,849 | 2.48M |
| Free Cash Flow | — | — | 903.7K |
| Rev Growth | +15.4% | +15.4% | -3.0% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |